Cagrilintide is an investigational, long-acting amylin analog developed by Novo Nordisk for weight management and type 2 diabetes treatment. By mimicking the natural hormone amylin, it targets receptors in the brain to increase satiety, reduce appetite, and slow gastric emptying
Product Name:Cagrilintide
Other Name:Leuprorelin, Leuprolidine
CAS NO.:1415456-99-3
Purity:97%
Molecular Formula:C59H84N16O12
Molecular Weight:1209.4
Packing:1mg;5mg;10mg;50mg;100mg,1g or according to customer’s detail requirement.
Remark:Only for Scentific research purpose,not for human body.







